Citizens Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.74M | Buy |
21,689
+4,881
| +29% | +$643K | 0.03% | 264 |
|
|
2026
Q1 | $2.34M | Sell |
16,808
-2,625
| -14% | -$368K | 0.03% | 262 |
|
|
2025
Q4 | $2.39M | Buy |
19,433
+1,538
| +9% | +$187K | 0.03% | 265 |
|
|
2025
Q3 | $1.99M | Buy |
17,895
+376
| +2% | +$42.7K | 0.03% | 285 |
|
|
2025
Q2 | $1.94M | Buy |
17,519
+3,347
| +24% | +$356K | 0.03% | 261 |
|
|
2025
Q1 | $1.59M | Buy |
14,172
+4,145
| +41% | +$428K | 0.03% | 260 |
|
|
2024
Q4 | $926K | Buy |
10,027
+3,706
| +59% | +$334K | 0.02% | 306 |
|
|
2024
Q3 | $530K | Buy |
6,321
+337
| +6% | +$25.7K | 0.01% | 376 |
|
|
2024
Q2 | $411K | Buy |
5,984
+1,588
| +36% | +$106K | 0.01% | 397 |
|
|
2024
Q1 | $322K | Sell |
4,396
-768
| -15% | -$59.1K | 0.01% | 327 |
|
|
2023
Q4 | $418K | Buy |
5,164
+1,711
| +50% | +$133K | 0.01% | 300 |
|
|
2023
Q3 | $259K | Sell |
3,453
-17,410
| -83% | -$1.34M | 0.01% | 308 |
|
|
2023
Q2 | $1.61M | Sell |
20,863
-164
| -0.8% | -$13.1K | 0.06% | 180 |
|
|
2023
Q1 | $1.74M | Buy |
21,027
+1,464
| +7% | +$121K | 0.06% | 177 |
|
|
2022
Q4 | $1.68M | Buy |
19,563
+40
| +0.2% | +$3.17K | 0.07% | 157 |
|
|
2022
Q3 | $1.2M | Buy |
19,523
+3,273
| +20% | +$206K | 0.05% | 173 |
|
|
2022
Q2 | $1M | Hold |
16,250
| – | – | 0.04% | 199 |
|
|
2022
Q1 | $966K | Sell |
16,250
-3,269
| -17% | -$209K | 0.03% | 215 |
|
|
2021
Q4 | $1.4M | Sell |
19,519
-485
| -2% | -$33.4K | 0.05% | 187 |
|
|
2021
Q3 | $1.4M | Buy |
20,004
+3,354
| +20% | +$236K | 0.05% | 181 |
|
|
2021
Q2 | $1.15M | Sell |
16,650
-100
| -0.6% | -$6.68K | 0.05% | 164 |
|
|
2021
Q1 | $1.08M | Sell |
16,750
-125
| -0.7% | -$8.06K | 0.06% | 149 |
|
|
2020
Q4 | $983K | Sell |
16,875
-20
| -0.1% | -$1.21K | 0.06% | 153 |
|
|
2020
Q3 | $1.07M | Sell |
16,895
-2,567
| -13% | -$178K | 0.07% | 137 |
|
|
2020
Q2 | $1.5M | Sell |
19,462
-1,270
| -6% | -$97.3K | 0.1% | 122 |
|
|
2020
Q1 | $1.55M | Sell |
20,732
-51
| -0.2% | -$3.52K | 0.13% | 119 |
|
|
2019
Q4 | $1.35M | Buy |
20,783
+3,228
| +18% | +$210K | 0.09% | 125 |
|
|
2019
Q3 | $1.11M | Sell |
17,555
-380
| -2% | -$24.8K | 0.08% | 125 |
|
|
2019
Q2 | $1.21M | Sell |
17,935
-74
| -0.4% | -$4.87K | 0.09% | 121 |
|
|
2019
Q1 | $1.17M | Sell |
18,009
-466
| -3% | -$31K | 0.09% | 123 |
|
|
2018
Q4 | $1.16M | Buy |
18,475
+800
| +5% | +$55.9K | 0.1% | 108 |
|
|
2018
Q3 | $1.36M | Sell |
17,675
-368
| -2% | -$27.8K | 0.11% | 113 |
|
|
2018
Q2 | $1.28M | Buy |
18,043
+198
| +1% | +$14K | 0.11% | 114 |
|
|
2018
Q1 | $1.34M | Hold |
17,845
| – | – | 0.11% | 114 |
|
|
2017
Q4 | $1.28M | Sell |
17,845
-225
| -1% | -$17.1K | 0.1% | 112 |
|
|
2017
Q3 | $1.46M | Buy |
18,070
+25
| +0.1% | +$1.91K | 0.12% | 116 |
|
|
2017
Q2 | $1.28M | Sell |
18,045
-1,103
| -6% | -$73.4K | 0.11% | 114 |
|
|
2017
Q1 | $1.3M | Buy |
19,148
+13,600
| +245% | +$956K | 0.12% | 110 |
|
|
2016
Q4 | $397K | Sell |
5,548
-75,706
| -93% | -$5.63M | 0.04% | 173 |
|
|
2016
Q3 | $6.43M | Buy |
81,254
+1,394
| +2% | +$113K | 0.61% | 67 |
|
|
2016
Q2 | $6.66M | Buy |
79,860
+79,150
| +11,148% | +$7.02M | 0.64% | 65 |
|
|
2016
Q1 | $65K | Sell |
710
-532
| -43% | -$48K | 0.01% | 340 |
|
|
2015
Q4 | $125K | Buy |
+1,242
| New | +$129K | 0.01% | 277 |
|
Other funds holding GILD
Citizens Financial Group's GILD Position: Q2 2026 in Review
Citizens Financial Group increased its Gilead Sciences (GILD) stake by 29% in Q2 2026, buying an estimated $643K and bringing the position to 21,689 shares worth $2.74M. The position accounts for 0.03% of the portfolio, ranked #264.
Citizens Financial Group first reported a position in GILD in Q4 2015 and has held it in 43 quarters since. The position peaked at $6.66M in Q2 2016. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Citizens Financial Group held 21,689 shares of Gilead Sciences worth $2.74M as of Q2 2026.
- Citizens Financial Group bought 4,881 Gilead Sciences shares in Q2 2026, an estimated $643K.
- Gilead Sciences made up 0.03% of Citizens Financial Group's portfolio in Q2 2026, its #264 holding.
- Citizens Financial Group first reported a position in Gilead Sciences in Q4 2015 and has held it in 43 quarters since.
- Citizens Financial Group's Gilead Sciences position peaked at $6.66M in Q2 2016.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.